CRBP CIK: 1595097

Corbus Pharmaceuticals Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.0
FY22:
−39.8
FY23:
−45.1
FY24:
−48.7
FY25:
−85.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−54.6
FY22:
–
FY23:
–
FY24:
−37.7
FY25:
−78.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.6
FY22:
–
FY23:
–
FY24:
−40.2
FY25:
−78.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.6
FY22:
−42.3
FY23:
−44.6
FY24:
−40.2
FY25:
−78.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data